GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hantech Bio-Technology Co Ltd (ROCO:1294) » Definitions » Debt-to-Equity

Hantech Bio-Technology Co (ROCO:1294) Debt-to-Equity : 0.77 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Hantech Bio-Technology Co Debt-to-Equity?

Hantech Bio-Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$6.6 Mil. Hantech Bio-Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$300.5 Mil. Hantech Bio-Technology Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$398.1 Mil. Hantech Bio-Technology Co's debt to equity for the quarter that ended in Dec. 2023 was 0.77.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hantech Bio-Technology Co's Debt-to-Equity or its related term are showing as below:

ROCO:1294' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.16   Med: 0.62   Max: 0.8
Current: 0.77

During the past 5 years, the highest Debt-to-Equity Ratio of Hantech Bio-Technology Co was 0.80. The lowest was 0.16. And the median was 0.62.

ROCO:1294's Debt-to-Equity is ranked worse than
69.53% of 1654 companies
in the Consumer Packaged Goods industry
Industry Median: 0.4 vs ROCO:1294: 0.77

Hantech Bio-Technology Co Debt-to-Equity Historical Data

The historical data trend for Hantech Bio-Technology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hantech Bio-Technology Co Debt-to-Equity Chart

Hantech Bio-Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
0.16 0.62 0.80 0.42 0.77

Hantech Bio-Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Equity Get a 7-Day Free Trial 0.80 0.63 0.42 0.38 0.77

Competitive Comparison of Hantech Bio-Technology Co's Debt-to-Equity

For the Packaged Foods subindustry, Hantech Bio-Technology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hantech Bio-Technology Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's Debt-to-Equity falls into.


Hantech Bio-Technology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hantech Bio-Technology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.631 + 300.456) / 398.089
=0.77

Hantech Bio-Technology Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(6.631 + 300.456) / 398.089
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hantech Bio-Technology Co  (ROCO:1294) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hantech Bio-Technology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hantech Bio-Technology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hantech Bio-Technology Co (ROCO:1294) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hantech Bio-Technology Co Ltd (ROCO:1294) » Definitions » Debt-to-Equity
Comparable Companies
ROCO:2756 ROCO:6968 TPE:1220 ROCO:4109 ROCO:6886 ROCO:6578 ROCO:2726 ROCO:1271 TPE:1233 ROCO:6929 XSWX:NESN KHC XPAR:BN GIS SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
No. 60, Section 1, Zhongshan Road, Yuanlin, TWN
Website
https://www.htbios.com
Hantech Bio-Technology Co Ltd provides health food customization services and most styles of patented aluminum foil bag packaging for Taiwan's health food manufacturers for liquids, jelly, and crystal jelly and others.

Hantech Bio-Technology Co (ROCO:1294) Headlines

No Headlines